Abstract
Bacteriophage (phage) therapy is expected to become an alternative therapy for Pseudomonas aeruginosa infections. P. aeruginosa phage KPP23 is a newly isolated phage belonging to the family Siphoviridae and may be a therapeutic phage candidate. We report its complete genome, which comprises 62,774 bp of double-stranded DNA containing 95 open reading frames.
Highlights
Bacteriophage therapy is expected to become an alternative therapy for Pseudomonas aeruginosa infections
Phage therapy is expected to be useful as an alternative therapeutic measure in the treatment of drugresistant P. aeruginosa infections [2]
Phage KPP23 was isolated from a water sample collected from Urado Bay, Kochi City, Kochi, Japan, using P. aeruginosa strain PA101 as the host strain [6]
Summary
Bacteriophage (phage) therapy is expected to become an alternative therapy for Pseudomonas aeruginosa infections. Phage therapy is expected to be useful as an alternative therapeutic measure in the treatment of drugresistant P. aeruginosa infections [2]. To satisfy the eligibility criteria for use as a therapeutic phage, the phage genome must be assessed for the absence of the genes associated with lysogeny, pathogenicity, and drug resistance [3, 4]. A virulent Pseudomonas phage belonging to the family Siphoviridae is proposed as a therapeutic phage [5].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
